170 related articles for article (PubMed ID: 22144261)
1. RAFT-derived polymer-drug conjugates: poly(hydroxypropyl methacrylamide) (HPMA)-7-ethyl-10-hydroxycamptothecin (SN-38) conjugates.
Williams CC; Thang SH; Hantke T; Vogel U; Seeberger PH; Tsanaktsidis J; Lepenies B
ChemMedChem; 2012 Feb; 7(2):281-91. PubMed ID: 22144261
[TBL] [Abstract][Full Text] [Related]
2. Antibody conjugates of 7-ethyl-10-hydroxycamptothecin (SN-38) for targeted cancer chemotherapy.
Moon SJ; Govindan SV; Cardillo TM; D'Souza CA; Hansen HJ; Goldenberg DM
J Med Chem; 2008 Nov; 51(21):6916-26. PubMed ID: 18939816
[TBL] [Abstract][Full Text] [Related]
3. N-(2-hydroxypropyl)methacrylamide copolymers of a glutathione (GSH)-activated glyoxalase i inhibitor and DNA alkylating agent: synthesis, reaction kinetics with GSH, and in vitro antitumor activities.
Zheng ZB; Zhu G; Tak H; Joseph E; Eiseman JL; Creighton DJ
Bioconjug Chem; 2005; 16(3):598-607. PubMed ID: 15898727
[TBL] [Abstract][Full Text] [Related]
4. HPMA copolymer conjugates with reduced anti-CD20 antibody for cell-specific drug targeting. I. Synthesis and in vitro evaluation of binding efficacy and cytostatic activity.
Etrych T; Strohalm J; Kovár L; Kabesová M; Ríhová B; Ulbrich K
J Control Release; 2009 Nov; 140(1):18-26. PubMed ID: 19632282
[TBL] [Abstract][Full Text] [Related]
5. Tumor targeting by pH-sensitive, biodegradable, cross-linked N-(2-hydroxypropyl) methacrylamide copolymer micelles.
Zhou Z; Li L; Yang Y; Xu X; Huang Y
Biomaterials; 2014 Aug; 35(24):6622-35. PubMed ID: 24814427
[TBL] [Abstract][Full Text] [Related]
6. HPMA copolymer-1,5-diazaanthraquinone conjugates as novel anticancer therapeutics.
Vicent MJ; Manzanaro S; de la Fuente JA; Duncan R
J Drug Target; 2004; 12(8):503-15. PubMed ID: 15621676
[TBL] [Abstract][Full Text] [Related]
7. N-(2-hydroxypropyl)methacrylamide copolymer-6-(3-aminopropyl)-ellipticine conjugates. Synthesis, in vitro, and preliminary in vivo evaluation.
Searle F; Gac-Breton S; Keane R; Dimitrijevic S; Brocchini S; Sausville EA; Duncan R
Bioconjug Chem; 2001; 12(5):711-8. PubMed ID: 11562189
[TBL] [Abstract][Full Text] [Related]
8. Polymer-albumin conjugate for the facilitated delivery of macromolecular platinum drugs.
Dag A; Jiang Y; Karim KJ; Hart-Smith G; Scarano W; Stenzel MH
Macromol Rapid Commun; 2015 May; 36(10):890-7. PubMed ID: 25790077
[TBL] [Abstract][Full Text] [Related]
9. Highly effective anti-tumor nanomedicines based on HPMA copolymer conjugates with pirarubicin prepared by controlled RAFT polymerization.
Randárová E; Nakamura H; Islam R; Studenovský M; Mamoru H; Fang J; Chytil P; Etrych T
Acta Biomater; 2020 Apr; 106():256-266. PubMed ID: 32058082
[TBL] [Abstract][Full Text] [Related]
10. Polymeric phosphorylcholine-camptothecin conjugates prepared by controlled free radical polymerization and click chemistry.
Chen X; McRae S; Parelkar S; Emrick T
Bioconjug Chem; 2009 Dec; 20(12):2331-41. PubMed ID: 19899739
[TBL] [Abstract][Full Text] [Related]
11. N-(2-Hydroxypropyl)methacrylamide-based polymer conjugates with pH-controlled activation of doxorubicin for cell-specific or passive tumour targeting. Synthesis by RAFT polymerisation and physicochemical characterisation.
Chytil P; Etrych T; Kříž J; Subr V; Ulbrich K
Eur J Pharm Sci; 2010 Nov; 41(3-4):473-82. PubMed ID: 20696244
[TBL] [Abstract][Full Text] [Related]
12. Novel prodrugs of SN38 using multiarm poly(ethylene glycol) linkers.
Zhao H; Rubio B; Sapra P; Wu D; Reddy P; Sai P; Martinez A; Gao Y; Lozanguiez Y; Longley C; Greenberger LM; Horak ID
Bioconjug Chem; 2008 Apr; 19(4):849-59. PubMed ID: 18370417
[TBL] [Abstract][Full Text] [Related]
13. Development of HPMA copolymer-anticancer conjugates: clinical experience and lessons learnt.
Duncan R
Adv Drug Deliv Rev; 2009 Nov; 61(13):1131-48. PubMed ID: 19699249
[TBL] [Abstract][Full Text] [Related]
14. Do HPMA copolymer conjugates have a future as clinically useful nanomedicines? A critical overview of current status and future opportunities.
Duncan R; Vicent MJ
Adv Drug Deliv Rev; 2010 Feb; 62(2):272-82. PubMed ID: 20005271
[TBL] [Abstract][Full Text] [Related]
15. Polymer-drug conjugates, PDEPT and PELT: basic principles for design and transfer from the laboratory to clinic.
Duncan R; Gac-Breton S; Keane R; Musila R; Sat YN; Satchi R; Searle F
J Control Release; 2001 Jul; 74(1-3):135-46. PubMed ID: 11489490
[TBL] [Abstract][Full Text] [Related]
16. HPMA copolymer conjugates of paclitaxel and docetaxel with pH-controlled drug release.
Etrych T; Sírová M; Starovoytova L; Ríhová B; Ulbrich K
Mol Pharm; 2010 Aug; 7(4):1015-26. PubMed ID: 20518512
[TBL] [Abstract][Full Text] [Related]
17. Passive and active hepatoma tumor targeting of new N-(2-hydroxypropyl)methacrylamide copolymer conjugates: synthesis, characterization, and evaluation in vitro and in vivo.
Yuan J; Yuan B; Guo H; Zeng X; Wang X; Liao S; Li J; Jia Z; Song F; Wang F
J Biomater Sci Polym Ed; 2013; 24(12):1472-83. PubMed ID: 23829459
[TBL] [Abstract][Full Text] [Related]
18. HPMA copolymer-cyclic RGD conjugates for tumor targeting.
Pike DB; Ghandehari H
Adv Drug Deliv Rev; 2010 Feb; 62(2):167-83. PubMed ID: 19951733
[TBL] [Abstract][Full Text] [Related]
19. Galactosylated N-2-hydroxypropyl methacrylamide-b-N-3-guanidinopropyl methacrylamide block copolymers as hepatocyte-targeting gene carriers.
Qin Z; Liu W; Li L; Guo L; Yao C; Li X
Bioconjug Chem; 2011 Aug; 22(8):1503-12. PubMed ID: 21688826
[TBL] [Abstract][Full Text] [Related]
20. Antiangiogenic antitumor activity of HPMA copolymer-paclitaxel-alendronate conjugate on breast cancer bone metastasis mouse model.
Miller K; Eldar-Boock A; Polyak D; Segal E; Benayoun L; Shaked Y; Satchi-Fainaro R
Mol Pharm; 2011 Aug; 8(4):1052-62. PubMed ID: 21545170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]